Clinical Trial Update: Treosulfan Based Conditioning Myelodysplastic Syndrome (MDS) [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating treosulfan-based conditioning for myelodysplastic syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelodysplastic Syndrome

Drugs mentioned

• Treosulfan (treosulfan)

Snippet

Sponsor: medac GmbH | Conditions: Myelodysplastic Syndrome | Phase 2 | Status: COMPLETED